Prosperity Financial Group, Inc. Sellas Life Sciences Group, Inc. Put Options Transaction History
Prosperity Financial Group, Inc.
- $201 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SLS
# of Institutions
52Shares Held
14.5MCall Options Held
538KPut Options Held
26.3K-
Anson Funds Management LP Dallas, TX7.58MShares$14.6 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$5.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.58 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA689KShares$1.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$830,6100.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $39.7M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...